Fetal Cardiac Magnetic Resonance Imaging Using DUS Gating on 3T: Preliminary Experiences in Detection of CHD

University Hospital, Bonn1 site in 1 country100 target enrollmentMay 11, 2021

ConditionsCongenital Heart Disease Fetal Cardiac Disorder Heart Defect, Congenital

Overview

Phase: N/A
Intervention: Not specified
Conditions: Congenital Heart Disease
Sponsor: University Hospital, Bonn
Enrollment: 100
Locations: 1
Primary Endpoint: The number of heart defect characteristics detectable by DUS gated Cine MRI imaging
Last Updated: 4 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The aim of this clinical prospective study is to investigate the value of fetal cardiac magnetic resonance imaging using a new Doppler ultrasound based gating method for the detection of congenital heart desease.

Registry

clinicaltrials.gov

Start Date

May 11, 2021

End Date

September 2023

Last Updated

4 years ago

Study Type

Observational

Sex

Female

Investigators

Sponsor

University Hospital, Bonn

Responsible Party

Principal Investigator

Julian Alexander Luetkens

Principial Investigator, Senior Physician

University Hospital, Bonn

Eligibility Criteria

Inclusion Criteria

•fetuses in third trimenon
•congenital heart defect suspected by obstetric ultrasound

Exclusion Criteria

•pregnant women with contraindication for native MRI

Outcomes

Primary Outcomes

The number of heart defect characteristics detectable by DUS gated Cine MRI imaging

Time Frame: Up to 3 months after birth, cardiac MRI findings will be compared against fetal ultrasound gainst fetal ultrasounand against findings after birth (reference standard).

DUS gated Cine imaging will be applied to detect characteristics of clinically suspected congenital heart defects.